Trial Profile
Phase II Study of WT1 126-134 Peptide Vaccination in Combination With Adjuvants GM-CSF and KLH in Carcinomas
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs INNO 305 (Primary)
- Indications Cancer
- Focus Therapeutic Use
- 03 Dec 2005 New trial record.